Remove Drug Development Remove Molecular Biology Remove Protein Expression Remove Protein Production
article thumbnail

Advancements in upstream CLD for enhanced biotherapeutics production

Drug Discovery World

Across the biotherapeutics workflow The landscape of large molecule drug development has evolved significantly in recent decades. Recently, the pandemic has accelerated the development process while still maintaining safety and efficacy standards. This article is sponsored by Revvity. Biotechnol Bioeng 2012;118:2326.

article thumbnail

Driving efficiency across upstream bioprocess workflow

Drug Target Review

Transposon technologies are gaining traction due to their accuracy in integrating the gene of interest into the host genome, making them an important tool for accelerating large molecule drug development. In addition, machine learning can potentially provide predictive models to assist in reducing process gaps and enhance productivity.

article thumbnail

The future outlook for mRNA therapies

Drug Discovery World

The widespread recognition of the term “mRNA” by people around the world can be attributed to the development of Covid-19 vaccines.” mRNA-based approaches can produce proteins / peptides by using protein synthesis which is processed in a transfected cell 1.

Therapies 130